Stocks and Investing
Stocks and Investing
Fri, February 10, 2023
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
[ Fri, Feb 10th 2023
] - WOPRAI
Christopher Raymond Maintained (ABBV) at Buy with Increased Target to $163 on, Feb 10th, 2023
Christopher Raymond of Piper Sandler, Maintained "AbbVie Inc." (ABBV) at Buy with Increased Target from $157 to $163 on, Feb 10th, 2023.
Christopher has made no other calls on ABBV in the last 4 months.
There are 9 other peers that have a rating on ABBV. Out of the 9 peers that are also analyzing ABBV, 4 agree with Christopher's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Geoff Meacham of "B of A Securities" Maintained at Hold with Increased Target to $165 on, Wednesday, December 14th, 2022
- Navaan Ty of "Exane BNP Paribas" Initiated at Hold and Held Target at $169 on, Thursday, December 8th, 2022
- Justin Smith of "Societe Generale" Downgraded from Strong Buy to Hold on, Tuesday, November 8th, 2022
- Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $155 on, Monday, October 31st, 2022
These are the ratings of the 5 analyists that currently disagree with Christopher
- Gavin Clark-Gartner of "Evercore ISI Group" Maintained at Buy with Increased Target to $165 on, Thursday, February 9th, 2023
- Robyn Karnauskas of "Truist Securities" Reiterated at Strong Buy and Held Target at $180 on, Thursday, February 9th, 2023
- Gary Nachman of "BMO Capital" Maintained at Buy with Decreased Target to $167 on, Monday, February 6th, 2023
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $182 on, Tuesday, December 6th, 2022
- Trung Huynh of "Credit Suisse" Initiated at Buy and Held Target at $170 on, Friday, November 18th, 2022
Contributing Sources